Emmanuel Simantirakis
8PUBLICATIONS
45CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Apr 13, 2026
Kidney disease increases the risk of cardiovascular events in patients with device-detected atrial fibrillation: NOAH-AFNET 6.Andreas Goette, Marc D Lemoine, Alexander Fierenz
|Oct 20, 2025
Pulmonary Vein Isolation: Cornerstone of Atrial Fibrillation Ablation and Its Evolving Challenges. A Critical Review.Eleftherios M Kallergis, Emmanuel N Simantirakis
|Sep 01, 2025
Effects of anticoagulation in patients with device-detected atrial fibrillation and multiple stroke risk factors: a win ratio analysis of the NOAH-AFNET 6 trial.Nina Becher, Gina Köllner, Emanuele Bertaglia
|Sep 02, 2024
Anticoagulation in device-detected atrial fibrillation with or without vascular disease: a combined analysis of the NOAH-AFNET 6 and ARTESiA trials.Renate B Schnabel, Juan Benezet-Mazuecos, Nina Becher
|Aug 27, 2024
Anticoagulation in Patients With Device-Detected Atrial Fibrillation With and Without a Prior Stroke or Transient Ischemic Attack: The NOAH-AFNET 6 Trial.Hans Christoph Diener, Nina Becher, Susanne Sehner
|Apr 09, 2024
Oral anticoagulation in device-detected atrial fibrillation: effects of age, sex, cardiovascular comorbidities, and kidney function on outcomes in the NOAH-AFNET 6 trial.Gregory Y H Lip, Julius Nikorowitsch, Susanne Sehner
Pageof 2
Frequent Collaborators
5 joint publications
Alexander Fierenz
5 joint publications
Ulrich Schotten
5 joint publications
Antonia Zapf
5 joint publications
Eloi Marijon
5 joint publications
Paulus Kirchhof
5 joint publications
Tobias Toennis
4 joint publications
Gregory Chlouverakis
4 joint publications
Nina Becher
4 joint publications
Emanuele Bertaglia
4 joint publications
Melanie Calvert
